Pharmacy

Sterineb Respules Atrovent Respules

Home » Prescription Drugs 15 » Sterineb Respules Atrovent Respules

Ipratropium is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema and when used concomitantly with inhaled beta-agonists for asthma.Respules: Adults (including elderly) and adolescents over 12 years of age:Maintenance Treatment: 1 respule 3 to 4 times daily Acute Attacks: 1 respule; repeated doses can be administered until the patient is stable. The time interval between doses may be determined by the physician. Paediatric Respules:Children 6 to 12 years: 1 respule; repeated doses can be administered until the patient is stable. The time interval may be determined by the physician. Daily dosage exceeding 1mg in children under 12 years of age should be given under medical supervision. Under 6 years of age: 1 respule; should be given under medical supervision repeated doses can be administered until the patient is stable. The time interval may be determined by the physician. Ipratropium respules are commonly used in combination with 2-agonist to maximise bronchodilation.IPRATROPIUM RESPULES can be administered using a range of commercially available nebulising devices. Where wall oxygen is available it is best administered at a flow rate of 6 - 8 litres per minute.IPRATROPIUM Respules and disodium cromoglycate inhalation solutions that contain the preservative benzalkonium chloride should not be administered simultaneously in the same nebuliser as precipitation may occur.

Buy Sterineb Respules Atrovent Respules and other Prescription Drugs 15 products online at Medstore.

Buy Online at Medstore - Click Here!

About Sterineb Respules Atrovent Respules:

Product Type: Prescription Drugs 15

Sterineb Respules ( Atrovent Respules Generic Ipratropium bromide )

Sterineb Respules (Atrovent Respules Generic Ipratropium bromide)

Atrovent Respules Generic Ipratropium bromide

250mcg/mL 20 Respules 250mcg/mL 60 Respules 250mcg/mL 40 Respules 500mcg/1mL 60 Respules 500mcg/mL 20 Respules 500mcg/mL 40 Respules Atrovent Respules Generic Ipratropium bromide Sterineb Respules

View more Prescription Drugs 15

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.